| 张 颐,于爱军,严 妍,等.上皮性卵巢癌生化复发诊治中国专家共识（2025年版）[J].肿瘤学杂志,2025,31(4):273-279. |
| 上皮性卵巢癌生化复发诊治中国专家共识（2025年版） |
| Chinese Expert Consensus on the Diagnosis and Treatment of Biochemical Recurrence of Epithelial Ovarian Cancer （2025 Edition） |
| 投稿时间：2025-03-09 |
| DOI：10.11735/j.issn.1671-170X.2025.04.B001 |
|
 |
| 中文关键词: 卵巢肿瘤 生化复发 肿瘤标志物 专家共识 |
| 英文关键词:ovarian neoplasms biochemical recurrence tumor markers expert consensus |
| 基金项目:辽宁省重点研发项目（2024JH2/102500019）；2022年沈阳市科技计划（22-321-33-08）；沈阳市科技局2023年助力中国医科大学高质量发展专项（23-506-3-01-10） |
|
| 摘要点击次数: 0 |
| 全文下载次数: 0 |
| 中文摘要: |
| 摘 要：卵巢癌是女性生殖系统预后较差的恶性肿瘤之一，多数患者经过初始治疗后会复发，部分患者表现为临床复发前血清肿瘤标志物的升高，而缺乏影像学检查证据。目前卵巢癌生化复发的诊断及治疗尚无统一的规范，专家组参考现有指南共识及国内外相关文献，集体讨论形成卵巢癌生化复发诊治中国专家共识，以供临床决策借鉴。 |
| 英文摘要: |
| Abstract： Ovarian cancer is one of the common female reproductive malignant tumors with poor prognosis. Most patients experience recurrence after initial treatment， and some patients exhibit elevated serum tumor markers before clinical recurrence without imaging evidence. Currently， there is no unified standard for the diagnosis and treatment of biochemical recurrence of ovarian cancer. This Chinese expert consensus on the diagnosis and treatment of biochemical recurrence of ovarian cancer was developed by panel of exerts， based on existing guidelines， consensuses， and relevant domestic and international literature， to serve as a guidance for clinical management of the condition. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |